nodes	percent_of_prediction	percent_of_DWPC	metapath
Ramelteon—CYP1A2—Betaxolol—glaucoma	0.111	0.18	CbGbCtD
Ramelteon—CYP2C19—Methazolamide—glaucoma	0.0915	0.148	CbGbCtD
Ramelteon—CYP2C19—Timolol—glaucoma	0.0778	0.126	CbGbCtD
Ramelteon—CYP3A4—Pilocarpine—glaucoma	0.0655	0.106	CbGbCtD
Ramelteon—CYP1A2—Clonidine—glaucoma	0.061	0.0985	CbGbCtD
Ramelteon—CYP3A4—Brinzolamide—glaucoma	0.0514	0.0829	CbGbCtD
Ramelteon—CYP3A4—Dorzolamide—glaucoma	0.0496	0.0801	CbGbCtD
Ramelteon—CYP3A4—Methazolamide—glaucoma	0.0442	0.0714	CbGbCtD
Ramelteon—CYP3A4—Acetazolamide—glaucoma	0.0354	0.0571	CbGbCtD
Ramelteon—CYP3A4—Clonidine—glaucoma	0.032	0.0516	CbGbCtD
Ramelteon—MTNR1A—Small Ligand GPCRs—PTGFR—glaucoma	0.0156	0.115	CbGpPWpGaD
Ramelteon—MTNR1B—Small Ligand GPCRs—PTGFR—glaucoma	0.0156	0.115	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—ATOH7—glaucoma	0.00661	0.0488	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—ATOH7—glaucoma	0.00661	0.0488	CbGpPWpGaD
Ramelteon—Thinking abnormal—Pilocarpine—glaucoma	0.00378	0.0154	CcSEcCtD
Ramelteon—Depression—Carteolol—glaucoma	0.00356	0.0145	CcSEcCtD
Ramelteon—Depression—Levobunolol—glaucoma	0.00336	0.0137	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Latanoprost—glaucoma	0.00326	0.0133	CcSEcCtD
Ramelteon—Nausea—Physostigmine—glaucoma	0.00305	0.0125	CcSEcCtD
Ramelteon—Mental disability—Pilocarpine—glaucoma	0.003	0.0123	CcSEcCtD
Ramelteon—Anaphylactoid reaction—Acetazolamide—glaucoma	0.003	0.0122	CcSEcCtD
Ramelteon—Dysgeusia—Carteolol—glaucoma	0.00273	0.0111	CcSEcCtD
Ramelteon—MTNR1A—Circadian rythm related genes—OPN4—glaucoma	0.00263	0.0194	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—OPN4—glaucoma	0.00263	0.0194	CbGpPWpGaD
Ramelteon—Thinking abnormal—Betaxolol—glaucoma	0.00263	0.0107	CcSEcCtD
Ramelteon—Myalgia—Metipranolol—glaucoma	0.00256	0.0105	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Bimatoprost—glaucoma	0.00252	0.0103	CcSEcCtD
Ramelteon—Dysgeusia—Methazolamide—glaucoma	0.00247	0.0101	CcSEcCtD
Ramelteon—Depression—Bimatoprost—glaucoma	0.00241	0.00987	CcSEcCtD
Ramelteon—Influenza—Brimonidine—glaucoma	0.00241	0.00983	CcSEcCtD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00236	0.0174	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—MAS1—glaucoma	0.00236	0.0174	CbGpPWpGaD
Ramelteon—Influenza—Dorzolamide—glaucoma	0.0023	0.00938	CcSEcCtD
Ramelteon—Influenza—Travoprost—glaucoma	0.00229	0.00934	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Metipranolol—glaucoma	0.00224	0.00914	CcSEcCtD
Ramelteon—Somnolence—Metipranolol—glaucoma	0.00218	0.00892	CcSEcCtD
Ramelteon—Influenza—Pilocarpine—glaucoma	0.00217	0.00887	CcSEcCtD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00216	0.0159	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—OPN4—glaucoma	0.00216	0.0159	CbGpPWpGaD
Ramelteon—Depression—Brimonidine—glaucoma	0.00214	0.00874	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Dorzolamide—glaucoma	0.00213	0.00872	CcSEcCtD
Ramelteon—CYP1A2—Sulindac Metabolic Pathway—CYP1B1—glaucoma	0.00212	0.0157	CbGpPWpGaD
Ramelteon—Mental disability—Betaxolol—glaucoma	0.00209	0.00853	CcSEcCtD
Ramelteon—Arthralgia—Latanoprost—glaucoma	0.00208	0.00849	CcSEcCtD
Ramelteon—Anaphylactic shock—Methazolamide—glaucoma	0.00206	0.00841	CcSEcCtD
Ramelteon—Insomnia—Carteolol—glaucoma	0.00206	0.0084	CcSEcCtD
Ramelteon—Depression—Dorzolamide—glaucoma	0.00204	0.00834	CcSEcCtD
Ramelteon—Depression—Travoprost—glaucoma	0.00203	0.00831	CcSEcCtD
Ramelteon—Depression—Brinzolamide—glaucoma	0.00201	0.0082	CcSEcCtD
Ramelteon—Somnolence—Diclofenamide—glaucoma	0.00199	0.00812	CcSEcCtD
Ramelteon—MTNR1B—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00194	0.0143	CbGpPWpGaD
Ramelteon—MTNR1A—GPCRs, Class A Rhodopsin-like—PTGFR—glaucoma	0.00194	0.0143	CbGpPWpGaD
Ramelteon—Fatigue—Diclofenamide—glaucoma	0.00193	0.00787	CcSEcCtD
Ramelteon—Dysgeusia—Apraclonidine—glaucoma	0.00191	0.00781	CcSEcCtD
Ramelteon—CYP2C19—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00187	0.0138	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00185	0.0136	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—OPN4—glaucoma	0.00185	0.0136	CbGpPWpGaD
Ramelteon—Somnolence—Methazolamide—glaucoma	0.00183	0.00748	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Latanoprost—glaucoma	0.00182	0.00742	CcSEcCtD
Ramelteon—Fatigue—Methazolamide—glaucoma	0.00177	0.00725	CcSEcCtD
Ramelteon—Asthenia—Metipranolol—glaucoma	0.00176	0.0072	CcSEcCtD
Ramelteon—Dysgeusia—Acetazolamide—glaucoma	0.00171	0.00699	CcSEcCtD
Ramelteon—CYP2C19—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.0017	0.0126	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00166	0.0123	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—PTGFR—glaucoma	0.00166	0.0123	CbGpPWpGaD
Ramelteon—Myalgia—Apraclonidine—glaucoma	0.00166	0.00679	CcSEcCtD
Ramelteon—Dysgeusia—Brimonidine—glaucoma	0.00164	0.0067	CcSEcCtD
Ramelteon—Asthenia—Carteolol—glaucoma	0.00163	0.00667	CcSEcCtD
Ramelteon—Dizziness—Metipranolol—glaucoma	0.00162	0.00663	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Clonidine—glaucoma	0.00161	0.00658	CcSEcCtD
Ramelteon—Asthenia—Diclofenamide—glaucoma	0.0016	0.00655	CcSEcCtD
Ramelteon—Dysgeusia—Dorzolamide—glaucoma	0.00157	0.0064	CcSEcCtD
Ramelteon—Dysgeusia—Travoprost—glaucoma	0.00156	0.00638	CcSEcCtD
Ramelteon—Asthenia—Levobunolol—glaucoma	0.00154	0.0063	CcSEcCtD
Ramelteon—Depression—Clonidine—glaucoma	0.00154	0.0063	CcSEcCtD
Ramelteon—Dysgeusia—Brinzolamide—glaucoma	0.00154	0.00629	CcSEcCtD
Ramelteon—Headache—Metipranolol—glaucoma	0.00154	0.00628	CcSEcCtD
Ramelteon—Influenza—Betaxolol—glaucoma	0.00151	0.00616	CcSEcCtD
Ramelteon—Dizziness—Carteolol—glaucoma	0.0015	0.00614	CcSEcCtD
Ramelteon—Diarrhoea—Carbachol—glaucoma	0.00149	0.0061	CcSEcCtD
Ramelteon—Dysgeusia—Pilocarpine—glaucoma	0.00148	0.00605	CcSEcCtD
Ramelteon—Dizziness—Diclofenamide—glaucoma	0.00148	0.00604	CcSEcCtD
Ramelteon—Asthenia—Methazolamide—glaucoma	0.00148	0.00603	CcSEcCtD
Ramelteon—Diarrhoea—Levobunolol—glaucoma	0.00147	0.00601	CcSEcCtD
Ramelteon—CYP1A2—Synthesis of epoxy (EET) and dihydroxyeicosatrienoic acids (DHET)—CYP1B1—glaucoma	0.00146	0.0108	CbGpPWpGaD
Ramelteon—Nausea—Metipranolol—glaucoma	0.00146	0.00596	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Apraclonidine—glaucoma	0.00145	0.00593	CcSEcCtD
Ramelteon—Dizziness—Carbachol—glaucoma	0.00144	0.0059	CcSEcCtD
Ramelteon—Insomnia—Apraclonidine—glaucoma	0.00144	0.00589	CcSEcCtD
Ramelteon—Arthralgia—Brimonidine—glaucoma	0.00143	0.00583	CcSEcCtD
Ramelteon—Myalgia—Brimonidine—glaucoma	0.00143	0.00583	CcSEcCtD
Ramelteon—Anaphylactic shock—Acetazolamide—glaucoma	0.00142	0.00582	CcSEcCtD
Ramelteon—Headache—Carteolol—glaucoma	0.00142	0.00582	CcSEcCtD
Ramelteon—Dizziness—Levobunolol—glaucoma	0.00142	0.00581	CcSEcCtD
Ramelteon—Somnolence—Apraclonidine—glaucoma	0.00142	0.00579	CcSEcCtD
Ramelteon—Diarrhoea—Methazolamide—glaucoma	0.00141	0.00575	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—OPN4—glaucoma	0.00141	0.0104	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—OPN4—glaucoma	0.00141	0.0104	CbGpPWpGaD
Ramelteon—Upper respiratory tract infection—Betaxolol—glaucoma	0.0014	0.00573	CcSEcCtD
Ramelteon—Headache—Diclofenamide—glaucoma	0.0014	0.00572	CcSEcCtD
Ramelteon—Insomnia—Bimatoprost—glaucoma	0.0014	0.00571	CcSEcCtD
Ramelteon—Fatigue—Apraclonidine—glaucoma	0.00137	0.00561	CcSEcCtD
Ramelteon—Somnolence—Bimatoprost—glaucoma	0.00137	0.00561	CcSEcCtD
Ramelteon—Headache—Carbachol—glaucoma	0.00137	0.00559	CcSEcCtD
Ramelteon—Arthralgia—Dorzolamide—glaucoma	0.00136	0.00557	CcSEcCtD
Ramelteon—Arthralgia—Travoprost—glaucoma	0.00136	0.00554	CcSEcCtD
Ramelteon—Myalgia—Travoprost—glaucoma	0.00136	0.00554	CcSEcCtD
Ramelteon—Nausea—Carteolol—glaucoma	0.00135	0.00552	CcSEcCtD
Ramelteon—Headache—Levobunolol—glaucoma	0.00135	0.0055	CcSEcCtD
Ramelteon—Depression—Betaxolol—glaucoma	0.00134	0.00548	CcSEcCtD
Ramelteon—Arthralgia—Brinzolamide—glaucoma	0.00134	0.00547	CcSEcCtD
Ramelteon—Myalgia—Brinzolamide—glaucoma	0.00134	0.00547	CcSEcCtD
Ramelteon—Nausea—Diclofenamide—glaucoma	0.00133	0.00543	CcSEcCtD
Ramelteon—CYP1A2—Synthesis of (16-20)-hydroxyeicosatetraenoic acids (HETE)—CYP1B1—glaucoma	0.00133	0.0098	CbGpPWpGaD
Ramelteon—Dizziness—Latanoprost—glaucoma	0.00132	0.00538	CcSEcCtD
Ramelteon—Anaphylactic shock—Dorzolamide—glaucoma	0.00131	0.00534	CcSEcCtD
Ramelteon—CYP1A2—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.0013	0.00958	CbGpPWpGaD
Ramelteon—Nausea—Carbachol—glaucoma	0.0013	0.0053	CcSEcCtD
Ramelteon—Headache—Methazolamide—glaucoma	0.00129	0.00527	CcSEcCtD
Ramelteon—Myalgia—Pilocarpine—glaucoma	0.00129	0.00526	CcSEcCtD
Ramelteon—Arthralgia—Pilocarpine—glaucoma	0.00129	0.00526	CcSEcCtD
Ramelteon—Nausea—Levobunolol—glaucoma	0.00128	0.00521	CcSEcCtD
Ramelteon—Somnolence—Acetazolamide—glaucoma	0.00127	0.00518	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—PTGFR—glaucoma	0.00127	0.00935	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—PTGFR—glaucoma	0.00127	0.00935	CbGpPWpGaD
Ramelteon—Headache—Latanoprost—glaucoma	0.00125	0.0051	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Brimonidine—glaucoma	0.00125	0.00509	CcSEcCtD
Ramelteon—Insomnia—Brimonidine—glaucoma	0.00124	0.00505	CcSEcCtD
Ramelteon—Fatigue—Acetazolamide—glaucoma	0.00123	0.00502	CcSEcCtD
Ramelteon—Nausea—Methazolamide—glaucoma	0.00122	0.005	CcSEcCtD
Ramelteon—Somnolence—Brimonidine—glaucoma	0.00122	0.00497	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Dorzolamide—glaucoma	0.00119	0.00486	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Travoprost—glaucoma	0.00118	0.00484	CcSEcCtD
Ramelteon—Insomnia—Dorzolamide—glaucoma	0.00118	0.00483	CcSEcCtD
Ramelteon—Fatigue—Brimonidine—glaucoma	0.00118	0.00482	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Brinzolamide—glaucoma	0.00117	0.00478	CcSEcCtD
Ramelteon—Insomnia—Brinzolamide—glaucoma	0.00116	0.00474	CcSEcCtD
Ramelteon—Somnolence—Dorzolamide—glaucoma	0.00116	0.00474	CcSEcCtD
Ramelteon—Upper respiratory tract infection—Timolol—glaucoma	0.00115	0.00468	CcSEcCtD
Ramelteon—Asthenia—Apraclonidine—glaucoma	0.00114	0.00467	CcSEcCtD
Ramelteon—Somnolence—Brinzolamide—glaucoma	0.00114	0.00466	CcSEcCtD
Ramelteon—Fatigue—Dorzolamide—glaucoma	0.00113	0.0046	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Pilocarpine—glaucoma	0.00112	0.00459	CcSEcCtD
Ramelteon—Fatigue—Travoprost—glaucoma	0.00112	0.00458	CcSEcCtD
Ramelteon—Insomnia—Pilocarpine—glaucoma	0.00112	0.00456	CcSEcCtD
Ramelteon—Asthenia—Bimatoprost—glaucoma	0.00111	0.00453	CcSEcCtD
Ramelteon—Fatigue—Brinzolamide—glaucoma	0.00111	0.00452	CcSEcCtD
Ramelteon—Somnolence—Pilocarpine—glaucoma	0.0011	0.00448	CcSEcCtD
Ramelteon—Depression—Timolol—glaucoma	0.0011	0.00448	CcSEcCtD
Ramelteon—Diarrhoea—Apraclonidine—glaucoma	0.00109	0.00445	CcSEcCtD
Ramelteon—Dizziness—Apraclonidine—glaucoma	0.00105	0.0043	CcSEcCtD
Ramelteon—Dysgeusia—Betaxolol—glaucoma	0.00103	0.00421	CcSEcCtD
Ramelteon—Arthralgia—Clonidine—glaucoma	0.00103	0.0042	CcSEcCtD
Ramelteon—CYP3A4—Benzo(a)pyrene metabolism—CYP1B1—glaucoma	0.00102	0.00757	CbGpPWpGaD
Ramelteon—Asthenia—Acetazolamide—glaucoma	0.00102	0.00418	CcSEcCtD
Ramelteon—Dizziness—Bimatoprost—glaucoma	0.00102	0.00417	CcSEcCtD
Ramelteon—CYP3A4—Aflatoxin B1 metabolism—GSTM1—glaucoma	0.001	0.0074	CbGpPWpGaD
Ramelteon—Headache—Apraclonidine—glaucoma	0.000998	0.00408	CcSEcCtD
Ramelteon—CYP1A2—Estrogen Receptor Pathway—CYP1B1—glaucoma	0.000989	0.00731	CbGpPWpGaD
Ramelteon—Asthenia—Brimonidine—glaucoma	0.000981	0.00401	CcSEcCtD
Ramelteon—Diarrhoea—Acetazolamide—glaucoma	0.000975	0.00398	CcSEcCtD
Ramelteon—Headache—Bimatoprost—glaucoma	0.000968	0.00395	CcSEcCtD
Ramelteon—Nausea—Apraclonidine—glaucoma	0.000946	0.00387	CcSEcCtD
Ramelteon—Dizziness—Acetazolamide—glaucoma	0.000942	0.00385	CcSEcCtD
Ramelteon—MTNR1B—Circadian rythm related genes—NGFR—glaucoma	0.000938	0.00692	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—NGFR—glaucoma	0.000938	0.00692	CbGpPWpGaD
Ramelteon—Asthenia—Dorzolamide—glaucoma	0.000937	0.00383	CcSEcCtD
Ramelteon—Asthenia—Travoprost—glaucoma	0.000933	0.00381	CcSEcCtD
Ramelteon—Asthenia—Brinzolamide—glaucoma	0.000921	0.00376	CcSEcCtD
Ramelteon—Nausea—Bimatoprost—glaucoma	0.000917	0.00375	CcSEcCtD
Ramelteon—Dizziness—Brimonidine—glaucoma	0.000904	0.00369	CcSEcCtD
Ramelteon—Musculoskeletal discomfort—Clonidine—glaucoma	0.000898	0.00367	CcSEcCtD
Ramelteon—Myalgia—Betaxolol—glaucoma	0.000895	0.00366	CcSEcCtD
Ramelteon—Arthralgia—Betaxolol—glaucoma	0.000895	0.00366	CcSEcCtD
Ramelteon—Diarrhoea—Dorzolamide—glaucoma	0.000894	0.00365	CcSEcCtD
Ramelteon—Headache—Acetazolamide—glaucoma	0.000893	0.00365	CcSEcCtD
Ramelteon—Insomnia—Clonidine—glaucoma	0.000891	0.00364	CcSEcCtD
Ramelteon—MTNR1B—Circadian rythm related genes—NTRK1—glaucoma	0.000891	0.00658	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—NTRK1—glaucoma	0.000891	0.00658	CbGpPWpGaD
Ramelteon—Diarrhoea—Travoprost—glaucoma	0.00089	0.00364	CcSEcCtD
Ramelteon—Asthenia—Pilocarpine—glaucoma	0.000886	0.00362	CcSEcCtD
Ramelteon—Diarrhoea—Brinzolamide—glaucoma	0.000879	0.00359	CcSEcCtD
Ramelteon—Somnolence—Clonidine—glaucoma	0.000876	0.00358	CcSEcCtD
Ramelteon—CYP2C19—Tamoxifen metabolism—CYP1B1—glaucoma	0.000865	0.00639	CbGpPWpGaD
Ramelteon—Dizziness—Dorzolamide—glaucoma	0.000864	0.00353	CcSEcCtD
Ramelteon—Dizziness—Travoprost—glaucoma	0.00086	0.00351	CcSEcCtD
Ramelteon—Headache—Brimonidine—glaucoma	0.000857	0.0035	CcSEcCtD
Ramelteon—Fatigue—Clonidine—glaucoma	0.00085	0.00347	CcSEcCtD
Ramelteon—Dizziness—Brinzolamide—glaucoma	0.000849	0.00347	CcSEcCtD
Ramelteon—Nausea—Acetazolamide—glaucoma	0.000846	0.00346	CcSEcCtD
Ramelteon—Diarrhoea—Pilocarpine—glaucoma	0.000844	0.00345	CcSEcCtD
Ramelteon—Dysgeusia—Timolol—glaucoma	0.000841	0.00344	CcSEcCtD
Ramelteon—Headache—Dorzolamide—glaucoma	0.000818	0.00334	CcSEcCtD
Ramelteon—Dizziness—Pilocarpine—glaucoma	0.000816	0.00333	CcSEcCtD
Ramelteon—Headache—Travoprost—glaucoma	0.000815	0.00333	CcSEcCtD
Ramelteon—Nausea—Brimonidine—glaucoma	0.000812	0.00332	CcSEcCtD
Ramelteon—Headache—Brinzolamide—glaucoma	0.000804	0.00329	CcSEcCtD
Ramelteon—MTNR1A—GPCR downstream signaling—OPN4—glaucoma	0.000795	0.00587	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—OPN4—glaucoma	0.000795	0.00587	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Betaxolol—glaucoma	0.000782	0.00319	CcSEcCtD
Ramelteon—Insomnia—Betaxolol—glaucoma	0.000776	0.00317	CcSEcCtD
Ramelteon—Nausea—Dorzolamide—glaucoma	0.000776	0.00317	CcSEcCtD
Ramelteon—Headache—Pilocarpine—glaucoma	0.000773	0.00316	CcSEcCtD
Ramelteon—Nausea—Travoprost—glaucoma	0.000772	0.00316	CcSEcCtD
Ramelteon—Nausea—Brinzolamide—glaucoma	0.000763	0.00312	CcSEcCtD
Ramelteon—CYP1A2—Estrogen metabolism—CYP1B1—glaucoma	0.000763	0.00563	CbGpPWpGaD
Ramelteon—Fatigue—Betaxolol—glaucoma	0.00074	0.00302	CcSEcCtD
Ramelteon—Nausea—Pilocarpine—glaucoma	0.000733	0.003	CcSEcCtD
Ramelteon—Myalgia—Timolol—glaucoma	0.000731	0.00299	CcSEcCtD
Ramelteon—Arthralgia—Timolol—glaucoma	0.000731	0.00299	CcSEcCtD
Ramelteon—MTNR1A—Signaling by GPCR—OPN4—glaucoma	0.000722	0.00533	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—OPN4—glaucoma	0.000722	0.00533	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—PTGFR—glaucoma	0.000716	0.00528	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—PTGFR—glaucoma	0.000716	0.00528	CbGpPWpGaD
Ramelteon—Asthenia—Clonidine—glaucoma	0.000707	0.00289	CcSEcCtD
Ramelteon—Anaphylactic shock—Timolol—glaucoma	0.000701	0.00286	CcSEcCtD
Ramelteon—MTNR1A—Circadian rythm related genes—FAS—glaucoma	0.000698	0.00516	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—FAS—glaucoma	0.000698	0.00516	CbGpPWpGaD
Ramelteon—Diarrhoea—Clonidine—glaucoma	0.000674	0.00276	CcSEcCtD
Ramelteon—CYP1A2—Tamoxifen metabolism—CYP1B1—glaucoma	0.000674	0.00498	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000668	0.00493	CbGpPWpGaD
Ramelteon—Dizziness—Clonidine—glaucoma	0.000652	0.00266	CcSEcCtD
Ramelteon—MTNR1B—Signaling by GPCR—PTGFR—glaucoma	0.00065	0.0048	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—PTGFR—glaucoma	0.00065	0.0048	CbGpPWpGaD
Ramelteon—Musculoskeletal discomfort—Timolol—glaucoma	0.000639	0.00261	CcSEcCtD
Ramelteon—MTNR1B—GPCR ligand binding—SMO—glaucoma	0.000639	0.00471	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—SMO—glaucoma	0.000639	0.00471	CbGpPWpGaD
Ramelteon—Insomnia—Timolol—glaucoma	0.000634	0.00259	CcSEcCtD
Ramelteon—Somnolence—Timolol—glaucoma	0.000623	0.00255	CcSEcCtD
Ramelteon—Headache—Clonidine—glaucoma	0.000617	0.00252	CcSEcCtD
Ramelteon—Asthenia—Betaxolol—glaucoma	0.000616	0.00252	CcSEcCtD
Ramelteon—MTNR1B—Signaling Pathways—LRP12—glaucoma	0.000615	0.00454	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—LRP12—glaucoma	0.000615	0.00454	CbGpPWpGaD
Ramelteon—CYP1A2—Estrogen metabolism—GSTM1—glaucoma	0.00061	0.0045	CbGpPWpGaD
Ramelteon—MTNR1A—G alpha (i) signalling events—C3—glaucoma	0.000607	0.00448	CbGpPWpGaD
Ramelteon—MTNR1B—G alpha (i) signalling events—C3—glaucoma	0.000607	0.00448	CbGpPWpGaD
Ramelteon—Fatigue—Timolol—glaucoma	0.000604	0.00247	CcSEcCtD
Ramelteon—CYP3A4—Estrogen metabolism—CYP1B1—glaucoma	0.000589	0.00435	CbGpPWpGaD
Ramelteon—Diarrhoea—Betaxolol—glaucoma	0.000587	0.0024	CcSEcCtD
Ramelteon—Nausea—Clonidine—glaucoma	0.000585	0.00239	CcSEcCtD
Ramelteon—Dizziness—Betaxolol—glaucoma	0.000567	0.00232	CcSEcCtD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000553	0.00408	CbGpPWpGaD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—EDN1—glaucoma	0.000553	0.00408	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—EDN1—glaucoma	0.00054	0.00399	CbGpPWpGaD
Ramelteon—Headache—Betaxolol—glaucoma	0.000538	0.0022	CcSEcCtD
Ramelteon—CYP1A2—Melatonin metabolism and effects—CYP1B1—glaucoma	0.000521	0.00384	CbGpPWpGaD
Ramelteon—CYP3A4—Tamoxifen metabolism—CYP1B1—glaucoma	0.00052	0.00384	CbGpPWpGaD
Ramelteon—Nausea—Betaxolol—glaucoma	0.00051	0.00208	CcSEcCtD
Ramelteon—Asthenia—Timolol—glaucoma	0.000503	0.00205	CcSEcCtD
Ramelteon—MTNR1A—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000483	0.00357	CbGpPWpGaD
Ramelteon—MTNR1B—Class A/1 (Rhodopsin-like receptors)—C3—glaucoma	0.000483	0.00357	CbGpPWpGaD
Ramelteon—Diarrhoea—Timolol—glaucoma	0.00048	0.00196	CcSEcCtD
Ramelteon—CYP3A4—Estrogen metabolism—GSTM1—glaucoma	0.000471	0.00347	CbGpPWpGaD
Ramelteon—Dizziness—Timolol—glaucoma	0.000464	0.00189	CcSEcCtD
Ramelteon—CYP1A2—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000459	0.00339	CbGpPWpGaD
Ramelteon—CYP2C19—Melatonin metabolism and effects—APOE—glaucoma	0.00044	0.00325	CbGpPWpGaD
Ramelteon—Headache—Timolol—glaucoma	0.000439	0.00179	CcSEcCtD
Ramelteon—CYP2C19—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000432	0.00319	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—OPN4—glaucoma	0.000426	0.00315	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—OPN4—glaucoma	0.000426	0.00315	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—EDN1—glaucoma	0.000421	0.00311	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—EDN1—glaucoma	0.000421	0.00311	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—EDN1—glaucoma	0.000421	0.00311	CbGpPWpGaD
Ramelteon—Nausea—Timolol—glaucoma	0.000416	0.0017	CcSEcCtD
Ramelteon—MTNR1A—Signaling Pathways—HEYL—glaucoma	0.000396	0.00293	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HEYL—glaucoma	0.000396	0.00293	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—PTGFR—glaucoma	0.000384	0.00283	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—PTGFR—glaucoma	0.000384	0.00283	CbGpPWpGaD
Ramelteon—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000374	0.00276	CbGpPWpGaD
Ramelteon—CYP2C19—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000369	0.00272	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR ligand binding—C3—glaucoma	0.000368	0.00272	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR ligand binding—C3—glaucoma	0.000368	0.00272	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CYP1B1—glaucoma	0.00036	0.00266	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CYP1B1—glaucoma	0.00036	0.00266	CbGpPWpGaD
Ramelteon—CYP1A2—Tryptophan metabolism—CYP1B1—glaucoma	0.00036	0.00266	CbGpPWpGaD
Ramelteon—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—ABCA1—glaucoma	0.000354	0.00261	CbGpPWpGaD
Ramelteon—CYP1A2—Melatonin metabolism and effects—APOE—glaucoma	0.000343	0.00253	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—CYP1B1—glaucoma	0.000337	0.00249	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—SMO—glaucoma	0.000328	0.00242	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—SMO—glaucoma	0.000328	0.00242	CbGpPWpGaD
Ramelteon—CYP2C19—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000303	0.00224	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—RPTOR—glaucoma	0.0003	0.00222	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—RPTOR—glaucoma	0.0003	0.00222	CbGpPWpGaD
Ramelteon—CYP1A2—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000291	0.00215	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NCK2—glaucoma	0.000291	0.00215	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NCK2—glaucoma	0.000291	0.00215	CbGpPWpGaD
Ramelteon—CYP1A2—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000287	0.00212	CbGpPWpGaD
Ramelteon—CYP3A4—Tryptophan metabolism—CYP1B1—glaucoma	0.000278	0.00205	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTT1—glaucoma	0.000269	0.00199	CbGpPWpGaD
Ramelteon—MTNR1B—Circadian rythm related genes—TP53—glaucoma	0.000261	0.00193	CbGpPWpGaD
Ramelteon—MTNR1A—Circadian rythm related genes—TP53—glaucoma	0.000261	0.00193	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—HDAC9—glaucoma	0.000247	0.00183	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—HDAC9—glaucoma	0.000247	0.00183	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—EDN1—glaucoma	0.000238	0.00176	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—EDN1—glaucoma	0.000238	0.00176	CbGpPWpGaD
Ramelteon—CYP1A2—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000236	0.00174	CbGpPWpGaD
Ramelteon—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1B1—glaucoma	0.000225	0.00166	CbGpPWpGaD
Ramelteon—CYP3A4—Oxidation by Cytochrome P450—CYP1B1—glaucoma	0.000222	0.00164	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—EDN1—glaucoma	0.000216	0.0016	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—EDN1—glaucoma	0.000216	0.0016	CbGpPWpGaD
Ramelteon—MTNR1A—GPCR downstream signaling—C3—glaucoma	0.000208	0.00153	CbGpPWpGaD
Ramelteon—MTNR1B—GPCR downstream signaling—C3—glaucoma	0.000208	0.00153	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTT1—glaucoma	0.000202	0.00149	CbGpPWpGaD
Ramelteon—CYP2C19—Arachidonic acid metabolism—PTGS2—glaucoma	0.000195	0.00144	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—SMO—glaucoma	0.000194	0.00143	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—SMO—glaucoma	0.000194	0.00143	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling by GPCR—C3—glaucoma	0.000189	0.00139	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling by GPCR—C3—glaucoma	0.000189	0.00139	CbGpPWpGaD
Ramelteon—CYP3A4—Phase 1 - Functionalization of compounds—CYP1B1—glaucoma	0.000182	0.00134	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NTRK2—glaucoma	0.000177	0.00131	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NTRK2—glaucoma	0.000177	0.00131	CbGpPWpGaD
Ramelteon—CYP1A2—Phase II conjugation—GSTM1—glaucoma	0.000171	0.00126	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—PTGS2—glaucoma	0.000162	0.0012	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—CYP1B1—glaucoma	0.000161	0.00119	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—CYP1B1—glaucoma	0.000159	0.00117	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTT1—glaucoma	0.000157	0.00116	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—CDKN1B—glaucoma	0.000154	0.00113	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—CDKN1B—glaucoma	0.000154	0.00113	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NGFR—glaucoma	0.000152	0.00112	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NGFR—glaucoma	0.000152	0.00112	CbGpPWpGaD
Ramelteon—CYP1A2—Arachidonic acid metabolism—PTGS2—glaucoma	0.000152	0.00112	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.00015	0.00111	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NTRK1—glaucoma	0.000144	0.00107	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NTRK1—glaucoma	0.000144	0.00107	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CA5A—glaucoma	0.000142	0.00104	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NARFL—glaucoma	0.000142	0.00104	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN2B—glaucoma	0.000133	0.000982	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN2B—glaucoma	0.000133	0.000982	CbGpPWpGaD
Ramelteon—CYP2C19—Biological oxidations—GSTM1—glaucoma	0.000129	0.00095	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—VEGFA—glaucoma	0.000128	0.000944	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—EDN1—glaucoma	0.000128	0.000942	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—EDN1—glaucoma	0.000128	0.000942	CbGpPWpGaD
Ramelteon—CYP2C19—Metapathway biotransformation—GSTM1—glaucoma	0.000127	0.000936	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—CYP1B1—glaucoma	0.000125	0.000925	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—CYP1B1—glaucoma	0.000124	0.000913	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTT1—glaucoma	0.000121	0.000896	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NGF—glaucoma	0.000117	0.000866	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NGF—glaucoma	0.000117	0.000866	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CTSA—glaucoma	0.000117	0.000865	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—C3—glaucoma	0.000111	0.000823	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—C3—glaucoma	0.000111	0.000823	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NARFL—glaucoma	0.00011	0.000814	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA5A—glaucoma	0.00011	0.000814	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor—TNF—glaucoma	0.00011	0.000809	CbGpPWpGaD
Ramelteon—CYP1A2—Aryl Hydrocarbon Receptor Pathway—TNF—glaucoma	0.00011	0.000809	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—APOE—glaucoma	0.000104	0.000766	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—APOE—glaucoma	0.000104	0.000766	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CAV1—glaucoma	0.000103	0.000759	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CAV1—glaucoma	0.000103	0.000759	CbGpPWpGaD
Ramelteon—CYP1A2—Biological oxidations—GSTM1—glaucoma	0.0001	0.00074	CbGpPWpGaD
Ramelteon—CYP1A2—Metapathway biotransformation—GSTM1—glaucoma	9.88e-05	0.00073	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—FN1—glaucoma	9.79e-05	0.000723	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—FN1—glaucoma	9.79e-05	0.000723	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—CYP1B1—glaucoma	9.67e-05	0.000714	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—BAD—glaucoma	9.67e-05	0.000714	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—BAD—glaucoma	9.67e-05	0.000714	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—CYP1B1—glaucoma	9.54e-05	0.000704	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA5A—glaucoma	8.51e-05	0.000628	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NARFL—glaucoma	8.51e-05	0.000628	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—NOS3—glaucoma	7.78e-05	0.000574	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—NOS3—glaucoma	7.78e-05	0.000574	CbGpPWpGaD
Ramelteon—CYP3A4—Biological oxidations—GSTM1—glaucoma	7.73e-05	0.000571	CbGpPWpGaD
Ramelteon—CYP3A4—Metapathway biotransformation—GSTM1—glaucoma	7.63e-05	0.000563	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CA1—glaucoma	6.91e-05	0.00051	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—CDKN1B—glaucoma	6.74e-05	0.000497	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—CDKN1B—glaucoma	6.74e-05	0.000497	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CTSA—glaucoma	6.69e-05	0.000494	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CA2—glaucoma	6.32e-05	0.000467	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—MMP9—glaucoma	6.24e-05	0.000461	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—MMP9—glaucoma	6.24e-05	0.000461	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	6.18e-05	0.000456	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	6.18e-05	0.000456	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—VEGFA—glaucoma	5.6e-05	0.000414	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—VEGFA—glaucoma	5.6e-05	0.000414	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA1—glaucoma	5.38e-05	0.000398	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CTSA—glaucoma	5.21e-05	0.000385	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CA2—glaucoma	4.92e-05	0.000364	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—ABCA1—glaucoma	4.81e-05	0.000355	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CYP1B1—glaucoma	4.81e-05	0.000355	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—TXN—glaucoma	4.45e-05	0.000329	CbGpPWpGaD
Ramelteon—MTNR1A—Signaling Pathways—TP53—glaucoma	4.23e-05	0.000313	CbGpPWpGaD
Ramelteon—MTNR1B—Signaling Pathways—TP53—glaucoma	4.23e-05	0.000313	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA1—glaucoma	4.16e-05	0.000307	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—APOE—glaucoma	4.06e-05	0.0003	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—CAV1—glaucoma	4.03e-05	0.000297	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CTSA—glaucoma	4.02e-05	0.000297	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CA2—glaucoma	3.8e-05	0.000281	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—TXN—glaucoma	3.47e-05	0.000256	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTT1—glaucoma	3.45e-05	0.000255	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—APOE—glaucoma	3.17e-05	0.000234	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—glaucoma	3.14e-05	0.000232	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.78e-05	0.000206	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—ABCA1—glaucoma	2.75e-05	0.000203	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CYP1B1—glaucoma	2.75e-05	0.000203	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTT1—glaucoma	2.69e-05	0.000199	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—TXN—glaucoma	2.68e-05	0.000198	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—GSTM1—glaucoma	2.2e-05	0.000162	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—glaucoma	2.17e-05	0.00016	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—ABCA1—glaucoma	2.14e-05	0.000158	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CYP1B1—glaucoma	2.14e-05	0.000158	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTT1—glaucoma	2.08e-05	0.000153	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—MTHFR—glaucoma	1.94e-05	0.000144	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—APOE—glaucoma	1.81e-05	0.000134	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—CAV1—glaucoma	1.79e-05	0.000132	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—GSTM1—glaucoma	1.71e-05	0.000127	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—ABCA1—glaucoma	1.65e-05	0.000122	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CYP1B1—glaucoma	1.65e-05	0.000122	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—MTHFR—glaucoma	1.51e-05	0.000112	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—APOE—glaucoma	1.41e-05	0.000104	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—CAV1—glaucoma	1.4e-05	0.000103	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—NOS3—glaucoma	1.36e-05	0.0001	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—GSTM1—glaucoma	1.32e-05	9.76e-05	CbGpPWpGaD
Ramelteon—CYP2C19—Metabolism—PTGS2—glaucoma	1.24e-05	9.15e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—MTHFR—glaucoma	1.17e-05	8.63e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—APOE—glaucoma	1.09e-05	8.03e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—CAV1—glaucoma	1.08e-05	7.96e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—NOS3—glaucoma	1.06e-05	7.8e-05	CbGpPWpGaD
Ramelteon—CYP1A2—Metabolism—PTGS2—glaucoma	9.66e-06	7.13e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—NOS3—glaucoma	8.15e-06	6.02e-05	CbGpPWpGaD
Ramelteon—CYP3A4—Metabolism—PTGS2—glaucoma	7.46e-06	5.51e-05	CbGpPWpGaD
